SheMed raises $50M to expand women's GLP-1 weight management platform
London-based women's healthcare technology company SheMed has secured $50 million in funding.
WHAT IT DOES
The women's health company offers branded GLP-1 medications and a weight management platform. It first provides individuals with a GLP-1 blood test to screen for health markers and then it tailors one's treatment plan based on their health markers.
from MobiHealthNews Feed https://ift.tt/evETjJW
via shoppergalleries
Comments
Post a Comment